for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Zhejiang Hisun Pharmaceutical says receives approval to start selling coronavirus treatment - company filing

Feb 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd :

* RECEIVES APPROVAL TO START SELLING FAVIPIRAVIR AS POTENTIAL TREATMENT FOR NOVEL CORONAVIRUS - COMPANY FILING

* SAYS MUST STILL CONTINUE CLINICAL TRIALS AFTER FAVIPIRAVIR HITS MARKET AS POTENTIAL CORONAVIRUS TREATMENT - COMPANY FILING Source text in Chinese: here Further company coverage: (Reporting by Josh Horwitz; Editing by Alison Williams)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up